Back
AMREP Corp. 10K Form
Buy
52
AXR
AMREP Corp.
Last Price:
$19.04
Seasonality Move:
12.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-03-08 | 10Q | AXR/AMREP Corp. Quarterly |
| 2023-12-11 | 10Q | AXR/AMREP Corp. Quarterly |
| 2023-09-13 | 10Q | AXR/AMREP Corp. Quarterly |
| 2023-07-25 | 10K | AXR/AMREP Corp. Annual |
| 2023-03-13 | 10Q | AXR/AMREP Corp. Quarterly |
| 2022-12-12 | 10Q | AXR/AMREP Corp. Quarterly |
Receive AXR News And Ratings
See the #1 stock for the next 7 days that we like better than AXR
AXR Financial Statistics
Sales & Book Value
| Annual Sales: | $49.7M |
|---|---|
| Cash Flow: | $-4.3M |
| Price / Cash Flow: | 22.76 |
| Annual Sales: | $25.64 |
| Price / Book: | 0.74 |
Profitability
| EPS (TTM): | 1.95590 |
|---|---|
| Net Income (TTM): | $10.5M |
| Gross Margin: | $19.4M |
| Return on Equity: | 8.06% |
| Return on Assets: | 7.78% |
AMREP Corp. Earnings Forecast
Key AMREP Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for AXR is 39.01%.
-
The Selling, General & Administrative Expenses for AXR have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of AXR is 25.59% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 19 years.
AMREP Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Real Estate Management & Development |
| Sector: | Real Estate |
| Current Symbol: | AXR |
| CUSIP: | 032159 |
| Website: | amrepcorp.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 27.83 |
| Quick Ratio: | 11.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 7.98 |
|---|---|
| Forward P/E Ratio: | 11.52 |
AXR Technical Analysis vs Fundamental Analysis
Buy
52
AMREP Corp. (AXR)
is a Buy
Is AMREP Corp. a Buy or a Sell?
-
AMREP Corp. stock is rated a BuyThe current AMREP Corp. [AXR] share price is $18.90. The Score for AXR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.